Implied Podcast
Season 1
by Implied Podcast™
Ferrari just shocked Wall Street — raising its 2025 outlook while cutting its electric-vehicle targets in half. Investors wanted speed; Ferrari chose soul. In this episode of Implied, we break down why the stock plunged 15%, what the shift means for the brand’s legendary identity, and how the new Elettrica could decide Ferrari’s fate in the EV era. Passion or progress — can Ferrari have both?
McDonald’s is feeling the heat — U.S. sales are sliding, analysts are turning bearish, and even Ozempic might be eating into demand. In this episode of Implied, we break down why traffic is dipping, how the $5 Meal Deal and Monopoly promo could spark a rebound, and whether 48 straight years of dividend hikes can keep investors loyal. The world’s biggest fast-food chain isn’t broken… but it’s definitely being tested.
AMD just shocked the market with a multi-year deal to power OpenAI — including up to six gigawatts of compute and a potential 10% equity stake. The stock soared more than 20%, and for good reason: this partnership could add tens of billions in revenue and finally challenge Nvidia’s dominance. But can AMD actually deliver? In this episode of Implied, we break down why this is a moonshot moment — and what it means for the future of AI hardware.
Palantir just scored the biggest contract in its history — a $10 billion deal with the U.S. Army — but a leaked memo calling its system “very high risk” sent the stock tumbling. In this episode, we break down the clash between glory and doubt: security flaws, insider stock sales, analyst divisions, and what’s really at stake for the company that wants to be the brain of U.S. defense.
Humana stock just swung 20 points in a single day after CMS boosted its Medicare Advantage star ratings — a huge win on paper. But with a billion-dollar loss earlier this year, a lawsuit against the government, and fresh premium cuts squeezing margins, the big question is: is this a turnaround or just a temporary bounce? In this episode of Implied, we dig into Humana’s risky balancing act and what’s really at stake for investors.
TransUnion shares just plunged 11% after FICO announced it will bypass credit bureaus and sell scores directly to lenders — a direct threat to a decades-old profit model. Add in a July cyber breach that compromised millions of Americans’ data, and suddenly a “steady compounder” looks vulnerable
Pfizer just cut a headline-grabbing deal with Donald Trump to slash drug prices under “TrumpRx,” betting political goodwill is worth thinner margins. At the same time, it’s swinging big with a $7B obesity drug acquisition, fighting to catch up with Novo Nordisk and Eli Lilly. Add in fresh COVID vaccine results — and over 1,300 lawsuits tied to Depo-Provera — and Pfizer looks like a company juggling huge risks and opportunities.
Bloom Energy stock has skyrocketed from the teens to the mid-80s on the back of AI’s insatiable demand for power. With Oracle and American Electric Power signing on, Wall Street is buzzing — but analysts are split. Is this the clean-energy solution AI data centers desperately need, or just hype priced too far ahead of reality?
Electronic Arts just dropped a bombshell — a $55 billion buyout that takes the gaming giant private at $210 per share. The move comes after a rocky year of missed bookings, cancelled projects, and layoffs, but with Battlefield 6 and EA Sports FC still in the pipeline, the stakes couldn’t be higher. In this episode of Implied, we break down why EA walked away from Wall Street, the debt load they’re taking on, and what the Saudi-backed deal means for regulators, players, and investors.
Robinhood stock just ripped to record highs after landing a spot in the S&P 500 and posting blowout earnings. But the real story? They’re transforming from a trading app into a full-stack finance platform — rolling out banking perks, tokenized stock trading in Europe, and even a venture fund for retail investors.